HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick M Brunner Selected Research

Interleukin-7 Receptors (Interleukin 7 Receptor)

1/2021Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick M Brunner Research Topics

Disease

18Atopic Dermatitis (Atopic Eczema)
04/2024 - 07/2015
11Inflammation (Inflammations)
04/2024 - 11/2013
11Psoriasis (Pustulosis Palmaris et Plantaris)
08/2023 - 07/2015
3Neoplasms (Cancer)
01/2024 - 01/2021
2Eczema
11/2023 - 04/2020
2Pruritus (Itching)
11/2023 - 01/2019
2Hypersensitivity (Allergy)
11/2023 - 01/2022
2Asthma (Bronchial Asthma)
11/2023 - 01/2022
2COVID-19
08/2023 - 01/2021
2Hyperplasia
01/2018 - 12/2016
1Perioral Dermatitis
05/2024
1Dermatitis
04/2024
1Lymphoma (Lymphomas)
01/2024
1Hematologic Neoplasms (Hematological Malignancy)
01/2024
1Food Hypersensitivity (Food Allergy)
11/2023
1Rhinitis
11/2023
1Conjunctivitis
11/2023
1Exanthema (Rash)
08/2023
1Infections
08/2023
1Fibrosis (Cirrhosis)
01/2023
1Superinfection
01/2023
1Prurigo
01/2023
1Nasal Polyps (Nasal Polyp)
01/2022
1Rhinosinusitis
01/2022
1Eosinophilia
01/2022
1Aspirin-Induced Asthma
01/2022
1Atherosclerotic Plaque (Atheroma)
01/2022
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Mycosis Fungoides
01/2021
1Severe Acute Respiratory Syndrome
01/2021
1Erythema
01/2021
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2021
1Disease Progression
01/2021
1Blister (Bulla)
11/2020
1Rosacea (Acne Rosacea)
04/2020
1Folliculitis (Sycosis)
04/2020
1Actinic Keratosis
06/2019
1Atherosclerosis
01/2017
1Skin Diseases (Skin Disease)
01/2017
1Lichen Planus (Lichen Ruber Planus)
07/2015

Drug/Important Bio-Agent (IBA)

7RNA (Ribonucleic Acid)IBA
04/2024 - 11/2020
6Biomarkers (Surrogate Marker)IBA
08/2023 - 01/2016
6Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2017
4InterleukinsIBA
08/2023 - 01/2018
4CytokinesIBA
01/2019 - 07/2015
3dupilumabIBA
04/2024 - 04/2020
3Interleukin-12 (IL 12)IBA
08/2023 - 11/2013
2abrocitinibIBA
11/2023 - 08/2022
2Immunoglobulin A (IgA)IBA
11/2023 - 04/2020
2Ustekinumab (CNTO 1275)FDA Link
08/2023 - 01/2017
2SteroidsIBA
01/2021 - 01/2016
2LigandsIBA
06/2019 - 07/2015
2ChemokinesIBA
06/2019 - 07/2015
2Interleukin-22 (IL-22)IBA
01/2019 - 01/2018
2fezakinumabIBA
01/2019 - 01/2018
2Interleukin-17 (Interleukin 17)IBA
01/2018 - 07/2015
1ruxolitinibIBA
05/2024
1Surface Antigens (Surface Antigen)IBA
01/2024
1AntibodiesIBA
01/2024
1Janus KinasesIBA
12/2023
1Virus ReceptorsIBA
08/2023
1ixekizumabIBA
01/2023
1secukinumabIBA
01/2023
1antineoplaston A10 (A 10)IBA
01/2023
1SphingolipidsIBA
01/2023
1CollagenIBA
01/2023
1Janus Kinase 1IBA
08/2022
1Omalizumab (Xolair)FDA Link
01/2022
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022
1EnzymesIBA
01/2022
1Immunoglobulin E (IgE)IBA
01/2022
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022
1Cyclooxygenase 1IBA
01/2022
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2021
1VaccinesIBA
01/2021
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2021
1Interleukin-7 Receptors (Interleukin 7 Receptor)IBA
01/2021
1Interleukin-23 (Interleukin 23)IBA
01/2021
1AmphiregulinIBA
11/2020
1Protease Inhibitors (Protease Inhibitor)IBA
06/2019
1LipidsIBA
01/2018
1Monoclonal AntibodiesIBA
01/2018
1Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA
06/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017
1C-Reactive ProteinIBA
01/2017
1Macrophage Colony-Stimulating FactorIBA
01/2017
1Chemokine CX3CL1IBA
01/2017
1CD40 Ligand (CD40L)IBA
01/2017
1Keratin-16 (Keratin 16)IBA
12/2016
1Imiquimod (Aldara)FDA LinkGeneric
07/2015
1Interleukin-4 (Interleukin 4)IBA
07/2015
1Interleukin-12 Subunit p40IBA
07/2015
1CC ChemokinesIBA
07/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2015

Therapy/Procedure

4Therapeutics
01/2024 - 11/2013
1Lasers (Laser)
01/2021
1Topical Administration
01/2021